ProQR Therapeutics N.V. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
PRQR Nasdaq 2836 www.proqr.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ProQR Therapeutics N.V.

ProQR Reports First Human Validation of RNA Editing Platform in Liver Disease - Oct 2nd, 2026 2:02 am
ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor - Sep 23rd, 2026 6:00 am
ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026 - Sep 9th, 2026 6:00 am
ProQR to Participate in Upcoming Investor Conferences in September 2026 - Sep 2nd, 2026 6:00 am
Outlook Therapeutics, Inc. (OTLK) Reports Q3 Loss, Lags Revenue Estimates - Aug 14th, 2026 6:25 am
ProQR Announces Second Quarter 2026 Operating and Financial Results - Aug 13th, 2026 5:00 am
ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement - Jun 25th, 2026 4:35 am
ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform - Jun 25th, 2026 4:25 am
Undervalued Penny Stocks To Consider In June 2026 - Jun 8th, 2026 6:05 am
ProQR Therapeutics N.V. (NASDAQ:PRQR) Analysts Just Slashed This Year's Revenue Estimates By 22% - May 14th, 2026 6:25 am
ProQR Announces First Quarter 2026 Operating and Financial Results - May 12th, 2026 5:00 am
ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform - May 11th, 2026 6:00 am
3 Promising Penny Stocks With Market Caps Up To $600M - May 6th, 2026 12:05 pm
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 - May 4th, 2026 6:00 am
ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors - Apr 30th, 2026 6:00 am